In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Bioventus Inc (NASDAQ: BVS) closed the day trading at $9.55 down -2.85% from the previous closing price of $9.83. In other words, the price has decreased by -$2.85 from its previous closing price. On the day, 0.54 million shares were traded. BVS stock price reached its highest trading level at $9.9 during the session, while it also had its lowest trading level at $9.42.
Ratios:
For a better understanding of BVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.81. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 2.65 whereas as Long-Term Debt/Eq ratio is at 2.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on December 17, 2024, Upgraded its rating to Neutral and sets its target price to $13 from $12 previously.
On December 07, 2023, Canaccord Genuity Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $7.
Craig Hallum Upgraded its Hold to Buy on August 09, 2023, whereas the target price for the stock was revised from $4 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 23 ’24 when Singleton Mark Leonard sold 10,733 shares for $10.53 per share. The transaction valued at 113,018 led to the insider holds 105,162 shares of the business.
CHURCH KATRINA J sold 2,535 shares of BVS for $26,694 on Dec 23 ’24. The SVP & Chief Compliance Officer now owns 47,264 shares after completing the transaction at $10.53 per share. On Dec 23 ’24, another insider, D’Adamio Anthony, who serves as the SVP & General Counsel of the company, sold 5,848 shares for $10.53 each. As a result, the insider received 61,579 and left with 109,578 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BVS now has a Market Capitalization of 624262528 and an Enterprise Value of 1024354752. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.40 while its Price-to-Book (P/B) ratio in mrq is 4.20. Its current Enterprise Value per Revenue stands at 1.845 whereas that against EBITDA is 20.331.
Stock Price History:
Over the past 52 weeks, BVS has reached a high of $14.38, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -17.21%, while the 200-Day Moving Average is calculated to be 10.89%.
Shares Statistics:
Over the past 3-months, BVS traded about 384.45K shares per day on average, while over the past 10 days, BVS traded about 330190 shares per day. A total of 65.34M shares are outstanding, with a floating share count of 44.70M. Insiders hold about 31.62% of the company’s shares, while institutions hold 48.96% stake in the company. Shares short for BVS as of 1734048000 were 975982 with a Short Ratio of 2.54, compared to 1731628800 on 1161019. Therefore, it implies a Short% of Shares Outstanding of 975982 and a Short% of Float of 2.17.
